159 related articles for article (PubMed ID: 35468990)
41. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Sutcliffe S; Giovannucci E; Gaydos CA; Viscidi RP; Jenkins FJ; Zenilman JM; Jacobson LP; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1573-80. PubMed ID: 17684131
[TBL] [Abstract][Full Text] [Related]
42. Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior.
McDonald AC; Ragin CC; Jenkins FJ; Weissfeld J; Wilson J; Wheeler VW; Wilson JB; Bunker CH; Taioli E
J Med Virol; 2009 Feb; 81(2):264-70. PubMed ID: 19107975
[TBL] [Abstract][Full Text] [Related]
43. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.
Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF
Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203
[TBL] [Abstract][Full Text] [Related]
44. Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico.
Gonzalez-Aldaco K; Rebello Pinho JR; Roman S; Gleyzer K; Fierro NA; Oyakawa L; Ramos-Lopez O; Ferraz Santana RA; Sitnik R; Panduro A
PLoS One; 2016; 11(1):e0146258. PubMed ID: 26741362
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
Mbulaiteye SM; Atkinson JO; Whitby D; Wohl DA; Gallant JE; Royal S; Goedert JJ; Rabkin CS
J Clin Virol; 2006 Apr; 35(4):442-9. PubMed ID: 16414306
[TBL] [Abstract][Full Text] [Related]
46. Human herpesvirus 8 establishes a latent infection in prostates of Tobago men resulting in increased macrophage infiltration.
Henning JD; Bunker CH; Patrick AL; Jenkins FJ
Prostate; 2016 Jun; 76(8):735-43. PubMed ID: 26848067
[TBL] [Abstract][Full Text] [Related]
47. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
[TBL] [Abstract][Full Text] [Related]
48. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
49. Association of CD14 variant with prostate cancer in African American men.
Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
[TBL] [Abstract][Full Text] [Related]
50. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
[TBL] [Abstract][Full Text] [Related]
51. [Association of HLA-DQ and IFNL4 polymorphisms with hepatitis B virus infection and clearance].
Chen H; Fan JH; Chen WX; Guo JJ; Huang Y
Zhonghua Gan Zang Bing Za Zhi; 2017 Jul; 25(7):506-511. PubMed ID: 29055988
[No Abstract] [Full Text] [Related]
52. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
[TBL] [Abstract][Full Text] [Related]
53. IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients.
Franco S; Aparicio E; Parera M; Clotet B; Tural C; Martinez MA
AIDS; 2014 Jan; 28(1):133-6. PubMed ID: 24072198
[TBL] [Abstract][Full Text] [Related]
54. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.
Fujino H; Imamura M; Nagaoki Y; Kawakami Y; Abe H; Hayes CN; Kan H; Fukuhara T; Kobayashi T; Masaki K; Ono A; Nakahara T; Honda Y; Naeshiro N; Urabe A; Yokoyama S; Miyaki D; Murakami E; Kawaoka T; Hiraga N; Tsuge M; Hiramatsu A; Hyogo H; Aikata H; Takahashi S; Miki D; Ochi H; Ohishi W; Chayama K;
J Gastroenterol; 2014 Dec; 49(12):1548-56. PubMed ID: 24362944
[TBL] [Abstract][Full Text] [Related]
55. Distribution of
Sorrentino L; Silvestri V; Oliveto G; Scordio M; Frasca F; Fracella M; Bitossi C; D'Auria A; Santinelli L; Gabriele L; Pierangeli A; Mastroianni CM; d'Ettorre G; Antonelli G; Caruz A; Ottini L; Scagnolari C
Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208821
[TBL] [Abstract][Full Text] [Related]
56. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
[TBL] [Abstract][Full Text] [Related]
57. Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya.
Baeten JM; Chohan BH; Lavreys L; Rakwar JP; Ashley R; Richardson BA; Mandaliya K; Bwayo JJ; Kreiss JK
AIDS; 2002 Oct; 16(15):2073-8. PubMed ID: 12370507
[TBL] [Abstract][Full Text] [Related]
58. Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance.
Fan JH; Hou SH; Qing-Ling L; Hu J; Peng H; Guo JJ
Ann Hepatol; 2016; 15(4):532-9. PubMed ID: 27236152
[TBL] [Abstract][Full Text] [Related]
59. IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.
Real LM; Herrero R; Rivero-Juárez A; Camacho Á; Macías J; Vic S; Soriano V; Viedma S; Guardiola JM; Fibla J; Rivero A; Pineda JA; Caruz A
AIDS; 2015 Sep; 29(14):1895-7. PubMed ID: 26372394
[TBL] [Abstract][Full Text] [Related]
60. The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection.
Jalilian S; Latifi SM; Makvandi M; Teimoori A; Azaran A; Parsanahad M; Kayedani G
Indian J Med Microbiol; 2017; 35(2):262-268. PubMed ID: 28681817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
